Pharmacy-Based HIV prevention shots could make PrEP easier
NCT ID NCT07210125
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 27 times
Summary
This study looks at whether getting the long-acting HIV prevention shot lenacapavir at a community pharmacy helps people stick with their PrEP routine. About 75 HIV-negative adults will receive the shot every 6 months and have either twice-yearly or quarterly pharmacy visits. Researchers will track how many people stay on PrEP and whether STI rates change.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kelley-Ross Pharmacy
Seattle, Washington, 98122, United States
Conditions
Explore the condition pages connected to this study.